What dose of Anti-D (Rho(D) immune globulin) should be administered to an RhD negative mother who received Anti-D at 24 weeks of gestation and has delivered an RhD positive baby?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postpartum Anti-D Dosing for Rh-Negative Mother

Give 300 micrograms (option A) of Anti-D immune globulin within 72 hours of delivery, as this is the standard postpartum dose recommended by ACOG and international guidelines for an Rh-negative mother who delivered an Rh-positive baby. 1, 2

Standard Postpartum Protocol

The mother should receive the full standard postpartum dose despite having received antenatal prophylaxis at 24 weeks, because:

  • The antenatal dose at 28 weeks (or in this case 24 weeks) does NOT replace the postpartum dose - these are two separate components of the prophylaxis protocol designed to work together 1
  • The two-dose protocol (antenatal + postpartum) reduces RhD alloimmunization from approximately 1.8% to between 0.1% and 0.2%, compared to postpartum dosing alone which only reduces it from 13-17% to 1-2% 1
  • Approximately 90% of fetomaternal hemorrhage occurs during delivery itself, making the postpartum dose critical regardless of prior antenatal prophylaxis 3

Dosing Specifications

  • Standard dose: 300 micrograms (1500 IU) IM or IV within 72 hours of delivery 2
  • Alternative acceptable regimen: 120 micrograms may be used if that is the available preparation, though testing for fetomaternal hemorrhage >6 mL fetal RBCs would then be required 2
  • If the 72-hour window is missed, Anti-D should still be administered up to 28 days postpartum, as delayed administration provides some protection and is preferable to none 1, 2

Critical Additional Considerations

Screen for excessive fetomaternal hemorrhage in this patient, particularly since she received antenatal Anti-D earlier than the standard 28 weeks (given at 24 weeks instead):

  • If fetomaternal hemorrhage exceeds 15 mL of fetal red blood cells (approximately 30 mL of fetal blood), additional Anti-D is required at 10 micrograms per 0.5 mL of fetal red blood cells 2
  • Quantitative testing (such as Kleihauer-Betke or flow cytometry) should be considered to determine if additional doses are needed 2, 4
  • The standard 300 microgram dose covers up to 15 mL of fetal RBCs; larger hemorrhages require supplemental dosing 2

Common Pitfalls to Avoid

  • Do not withhold the postpartum dose assuming the antenatal dose at 24 weeks provides adequate coverage - both doses are required for optimal protection 1
  • Do not delay beyond 72 hours - efficacy decreases with time, though late administration is still beneficial up to 28 days 1, 2
  • Do not forget to confirm the baby is actually Rh-positive before administering, though if testing is unavailable or delayed, administer Anti-D rather than risk sensitization 1

References

Guideline

Management Guidelines for Rh Negative Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of Rh alloimmunization.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003

Guideline

Rh Incompatibility and Jaundice in First Babies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Guidelines for the Management of a Pregnant Trauma Patient.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.